Loading…
Palliative Care and Hospice Education and Training Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,357 other S bills in the 117th — cohort avg 38d
Palliative Care and Hospice Education and Training Act This bill requires the Department of Health and Human Services (HHS) to take a series of actions relating to palliative-care training. Specifically, HHS must provide support for Palliative Care and Hospice Education Centers. The centers must improve the training of health professionals in palliative care and establish traineeships for individuals preparing for advanced-education nursing degrees, social-work degrees, or advanced degrees in physician-assistant studies in palliative care. HHS may provide support to medical schools, teaching hospitals, and graduate medical-education programs for training physicians who plan to teach palliative medicine. HHS must (1) provide Palliative Medicine and Hospice Academic Career Awards to individuals to promote their career development, (2) support entities that operate a Palliative Care and Hospice Education Center, (3) support individuals in specified fields who are pursuing an advanced degree in palliative care or related fields, and (4) award grants to nursing programs to train individuals in providing palliative care. The Agency for Healthcare Research and Quality must provide for a national education and awareness campaign to inform patients, families, and health professionals about the benefits of palliative care. The National Institutes of Health must expand national research programs in palliative care.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (13)
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2024 · fourth_quarter · Health Issues
S.4260, Palliative Care and Hospice Education and Training Act
Client expense: Not reported · Firm income: $30,000
Government targets: SENATE
2024 · fourth_quarter · Labor Issues/Antitrust/Workplace
Government-mandated project labor agreements (PLAs) on federal and federally assisted construction projects. Executive Order 13202: Preservation of Open Competition and Government Neutrality Towards Government Contractors and Labor Relations on Federal and Federally Funded Construction Projects - February 17, 2001. Davis-Bacon Act. Executive Order 13502: Use of Project Labor Agreement for Federal Construction Projects - February 6, 2009. Proposal to expand Executive Order 13502: Use of Project Labor Agreements on Federal Construction Projects - February 6, 2009. H.R. 1209/S.537: the Fair and Open Competition Act. H.R. 20/S. 567: the Richard L. Trumka Protecting the Right to Organize Act of 2023. Apprenticeship Programs, generally. Apprenticeship Requirements on Federal Contracts. Workforce development, generally. Fair Pay and Safe Workplaces/Blacklisting policies. Fair Labor Standards Act. National Labor Relations Act. DOL-OSHA (Reg.) Title: Heat Injury and Illness Prevention in Outdoor and Indoor Work Setting (RIN: 1218-AD39). Executive Order 14063: Use of Project Labor Agreements for Federal Construction Projects. DOL-WHD (Reg.) Title: Updating the Davis-Bacon and Related Acts Regulations (RIN: 1235-AA40). The Infrastructure Investment and Jobs Act (PL 117-58). FAR Council (Reg.) Title: Federal Acquisition Regulation: Use of Project Labor Agreements for Federal Construction Projects (RIN: 9000-AO40). DOL-WHD Reg (Title): Employee or Independent Contractor Classification Under the Fair Labor Standards Act (RIN: 1235-AA43). DOL-WHD (Reg.) Title: Independent Contractor Status Under the Fair Labor Standards Act; (RIN 1235-AA34) Inflation Reduction Act of 2022. OSHA compliance and enforcement, generally. DOL Secretary of Labor nominee, Julie Su. Notice of Funding Opportunity (NOFO) - CHIPS Incentives Program - Commercial Fabrication Facilities. Policy changes made by the NLRB that would impact free speech, open debate, the right to cast a vote privately, and the promise of a workplace free from harassment. H.R. 2700/S. 1201: the Employee Rights Act. H.R. 720: the Davis Bacon Repeal Act. NLRB (Reg.) Title: Standard for Determining Joint Employer Status (RIN: 3142-AA21). NLRB (Reg.) Title: Joint Employer Status under the National Labor Relations Act (RIN: 3142-AA13). Health and Safety, generally. DOL-OSHA (Reg.) Title: Worker Walkaround Designation Process (RIN: 1218-AD45). DOL-WHD (Reg.) Title: Defining and Delimiting the Exemptions for Executive, Administrative, Professional, Outside Sales, and Computer Employees (RIN: 1235-AA39). DOL-WHD (Reg.) Title: Defining and Delimiting the Exemptions for Executive, Administrative, Professional, Outside Sales and Computer Employees (RIN: 1235-AA20). DOL-ETA (Reg.) Title: National Apprenticeship System Enhancements (RIN: 1205-AC13). National Electric Vehicle Infrastructure Formula Program, generally. Treasury-IRS (Reg.) Title: Increased Credit or Deduction Amounts for Satisfying Certain Prevailing Wage and Registered Apprenticeship Requirements (RIN: 1545-BQ54). Workforce Innovation and Opportunity Act reauthorization, generally. H.J.Res.98/S.J.Res.49: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the National Labor Relations Board relating to "Standard for Determining Joint Employer Status." H.J.Res.103: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Labor relating to "Updating the Davis-Bacon and Related Acts Regulation." Tax Cuts and Jobs Act, generally. H.R. 6585: Bipartisan Workforce Pell Act. H.J.Res.116/S.J.Res.63: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of the Labor relating to "Employee or Independent Contractor Classification Under the Fair Labor Standards Act". H.R. 7784: Start Applying Labor Transparency Act. H.R. 7367: Overtime Pay Flexibility Act. NLRB interpretations that would protect harassing behavior in the workplace and create potential conflicts with federal, state, and local anti-discrimination laws. NLRB members recusal obligations. Concerns with efforts to overturn significant precedent at the NLRB, including the General Counsels memos on captive audience meetings and electronic monitoring of workers as well as the Boards anticipated decision in Ralphs Grocery. NLRBs decisions in Cemex, American Steel Construction, Thryc, Inc., The Atlanta Opera, and Stericycle. Senate HELP Committee Chairs announcement to hold a vote to authorize investigations into major corporations labor practices. National Labor Relations Board Chair nominee, Lauren McFerran. H.J.Res.147: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Occupational Safety and Health Administration relating to "Worker Walkaround Representative Designation Process." H.J.Res.166: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Labor relating to "Defining and Delimiting the Exemptions for Executive, Administrative, Professional, Outside Sales, and Computer Employees." H.J.Res.132: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Defense, the General Services Administration, and the National Aeronautics and Space Administration relating to the "Federal Acquisition Regulation: Use of Project Labor Agreements for Federal Construction Projects." S. 4260: Warehouse Worker Protection Act. Executive Order 14126: Investing in America and Investing in American Workers. H.R. 9461: USA Workforce Investment Act. H.J.Res.203: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the National Labor Relations Board relating to "Representation-Case Procedures: Election Bars; Proof of Majority Support in Construction Industry Collective-Bargaining Relationships". East and Gulf Coast ports strike negotiations, generally. H.R. 6655: A Stronger Workforce for America Act. Second Chance Reauthorization Act of 2024.
2024 · third_quarter · Health Issues
S.4260, Palliative Care and Hospice Education and Training Act
Client expense: Not reported · Firm income: $30,000
Government targets: SENATE
2024 · second_quarter · Health Issues
S.4260, Palliative Care and Hospice Education and Training Act
Client expense: Not reported · Firm income: $30,000
Government targets: SENATE
2024 · second_quarter · Labor Issues/Antitrust/Workplace
Government-mandated project labor agreements (PLAs) on federal and federally assisted construction projects. Executive Order 13202: Preservation of Open Competition and Government Neutrality Towards Government Contractors and Labor Relations on Federal and Federally Funded Construction Projects - February 17, 2001. Davis-Bacon Act. Executive Order 13502: Use of Project Labor Agreement for Federal Construction Projects - February 6, 2009. Proposal to expand Executive Order 13502: Use of Project Labor Agreements on Federal Construction Projects - February 6, 2009. H.R. 1209/S.537: the Fair and Open Competition Act. H.R. 20/S. 567: the Richard L. Trumka Protecting the Right to Organize Act of 2023. Apprenticeship Programs, generally. Apprenticeship Requirements on Federal Contracts. Workforce development, generally. Fair Pay and Safe Workplaces/Blacklisting policies. Fair Labor Standards Act. National Labor Relations Act. DOL-OSHA (Reg.) Title: Heat Injury and Illness Prevention in Outdoor and Indoor Work Setting (RIN: 1218-AD39). Executive Order 14063: Use of Project Labor Agreements for Federal Construction Projects. DOL-WHD (Reg.) Title: Updating the Davis-Bacon and Related Acts Regulations (RIN: 1235-AA40). The Infrastructure Investment and Jobs Act (PL 117-58). FAR Council (Reg.) Title: Federal Acquisition Regulation: Use of Project Labor Agreements for Federal Construction Projects (RIN: 9000-AO40). DOL-WHD Reg (Title): Employee or Independent Contractor Classification Under the Fair Labor Standards Act (RIN: 1235-AA43). DOL-WHD (Reg.) Title: Independent Contractor Status Under the Fair Labor Standards Act; (RIN 1235-AA34) Inflation Reduction Act of 2022. OSHA compliance and enforcement, generally. DOL Secretary of Labor nominee, Julie Su. DOL Wage and Hour Administrator nominee, Jessica Looman. Notice of Funding Opportunity (NOFO) - CHIPS Incentives Program - Commercial Fabrication Facilities. Policy changes made by the NLRB that would impact free speech, open debate, the right to cast a vote privately, and the promise of a workplace free from harassment. H.R. 2700/S. 1201: the Employee Rights Act. H.R. 720: the Davis Bacon Repeal Act. NLRB (Reg.) Title: Standard for Determining Joint Employer Status (RIN: 3142-AA21). NLRB (Reg.) Title: Joint Employer Status under the National Labor Relations Act (RIN: 3142-AA13). Health and Safety, generally. DOL-OSHA (Reg.) Title: Worker Walkaround Designation Process Proposed Rule (RIN: 1218-AD45). DOL-WHD (Reg.) Title: Defining and Delimiting the Exemptions for Executive, Administrative, Professional, Outside Sales, and Computer Employees (RIN: 1235-AA39). DOL-WHD (Reg.) Title: Defining and Delimiting the Exemptions for Executive, Administrative, Professional, Outside Sales and Computer Employees (RIN: 1235-AA20). DOL-ETA (Reg.) Title: National Apprenticeship System Enhancements (RIN: 1205-AC13). National Electric Vehicle Infrastructure Formula Program, generally. Treasury-IRS (Reg.) Title: Increased Credit or Deduction Amounts for Satisfying Certain Prevailing Wage and Registered Apprenticeship Requirements (RIN: 1545-BQ54). H.R. 6655: A Stronger Workforce for America Act. H.J.Res.98/S.J.Res.49: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the National Labor Relations Board relating to "Standard for Determining Joint Employer Status." H.J.Res.103: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Labor relating to "Updating the Davis-Bacon and Related Acts Regulation." Tax Cuts and Jobs Act, generally. H.R. 6585: Bipartisan Workforce Pell Act. H.J.Res.116/S.J.Res.63: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of the Labor relating to "Employee or Independent Contractor Classification Under the Fair Labor Standards Act". H.R. 7784: Start Applying Labor Transparency Act. H.R. 7367: Overtime Pay Flexibility Act. NLRB interpretations that would protect harassing behavior in the workplace and create potential conflicts with federal, state, and local anti-discrimination laws. NLRB members recusal obligations. Concerns with efforts to overturn significant precedent at the NLRB, including the General Counsels memos on captive audience meetings and electronic monitoring of workers as well as the Boards anticipated decision in Ralphs Grocery. NLRBs decisions in Cemex, American Steel Construction, Thryc, Inc., The Atlanta Opera, and Stericycle. Senate HELP Committee Chairs announcement to hold a vote to authorize investigations into major corporations labor practices. National Labor Relations Board Chair nominee, Lauren McFerran. H.J.Res.147: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Occupational Safety and Health Administration relating to "Worker Walkaround Representative Designation Process." H.J.Res.166: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Labor relating to "Defining and Delimiting the Exemptions for Executive, Administrative, Professional, Outside Sales, and Computer Employees." H.J.Res.132: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Defense, the General Services Administration, and the National Aeronautics and Space Administration relating to the "Federal Acquisition Regulation: Use of Project Labor Agreements for Federal Construction Projects." S. 4260: Warehouse Worker Protection Act.
| Democratic |
| CT |
| Cindy Hyde-Smith | Republican | MS |
| Debbie Stabenow | Democratic | MI |
| Jack Reed | Democratic | RI |
| Jacky Rosen | Democratic | NV |
| James M. Inhofe | Republican | OK |
| Jeanne Shaheen | Democratic | NH |
| Jeff Merkley | Democratic | OR |
| Jerry Moran | Republican | KS |
| John Barrasso | Republican | WY |
| John Boozman | Republican | AR |
| Kirsten E. Gillibrand | Democratic | NY |
| Kyrsten Sinema | Independent | AZ |
| Lisa Murkowski | Republican | AK |
| Maria Cantwell | Democratic | WA |
| Mark Kelly | Democratic | AZ |
| Marsha Blackburn | Republican | TN |
| Mike Rounds | Republican | SD |
| Richard Blumenthal | Democratic | CT |
| Robert P. Casey, Jr. | Democratic | PA |
| Roger F. Wicker | Republican | MS |
| Roger Marshall | Republican | KS |
| Roy Blunt | Republican | MO |
| Sheldon Whitehouse | Democratic | RI |
| Shelley Moore Capito | Republican | WV |
| Sherrod Brown | Democratic | OH |
| Susan M. Collins | Republican | ME |
| Tina Smith | Democratic | MN |
Client expense: $700,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT)
Client expense: $700,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT)
2024 · first_quarter · Health Issues
S.4260, Palliative Care and Hospice Education and Training Act
Client expense: Not reported · Firm income: $30,000
Government targets: SENATE
2023 · fourth_quarter · Health Issues
S.4260, Palliative Care and Hospice Education and Training Act
Client expense: Not reported · Firm income: $30,000
Government targets: SENATE
2023 · first_quarter · Health Issues
Articulated CHAs Vision for Health Care in the U.S. and the advocacy priorities of the Catholic health ministry and urged Congress to provide access, coverage and affordability for all Americans, ensure a strong safety net, strengthen aging and chronic care services, and protect life and ensure conscience protection. (S.4260) - Palliative Care and Hospice Education and Training Act (PCHETA). Urged Congress to support the Palliative Care and Hospice Education and Training Act. This legislation would address the palliative care workforce shortage and help respond to pressing issues including appropriate pain management and pandemic preparedness. Responded to the Senate HELP Committee's request for information on the drivers of and solutions for addressing our nations health care workforce shortages.
Client expense: $210,731 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Health Issues
H.R. 379/S. 104 - Improving Social Determinants of Health Act; bill to require the Centers for Disease Control and Prevention (CDC) to establish a program to improve health outcomes and reduce health inequities by, for example, coordinating activities across the CDC. As part of the program, the CDC must award grants to eligible organizations to build capacity to address social determinants of health. H.R. 469 - Comprehensive Breast Reconstruction Act of 2021; bill provides for Medicare, Medicaid, and private health insurance coverage of certain tattooing services in connection with post-mastectomy breast reconstruction, and aligns the scope of Medicare and Medicaid coverage of such breast reconstruction with that of private health insurance. H.R. 5030/S.2706 - DIVERSE Trials Act; A bill to require FDA to issue guidance on decentralized clinical trials to promote meaningful demographic/geographic diversity in patient engagement, expand reporting by laboratories that test for and diagnose COVID-19, and require a study on data collection and data sharing during public health emergencies H.R. 6000 - Cures 2.0 Act; a comprehensive healthcare and biomedical research bill H.R. 4794/S. 2533 - Making Advances in Mammography and Medical Options for Veterans Act; a bill to improve mammography services furnished by the Department of Veterans Affairs H.R. 4571/S. 2102 - Supporting Expanded Review for Veterans in Combat Environments (SERVICE) Act of 2021; a bill to expand eligibility for Veterans Health Administration mammography screenings to veterans who served in certain locations during specified periods, including those who were exposed to toxic substances at such locations H.R. 6584 - Diverse and Equitable Participation in Clinical Trials (DEPICT) Act; a bill to direct the Commissioner of Food and Drugs to amend certain regulations to increase clinical trial diversity, and for other purposes. S. 3799 - Prepare for and Respond to Existing Viruses, Emerging New Threats, (PREVENT) and Pandemics Act; a bill to prepare for, and respond to, existing viruses, emerging new threats, and pandemics. H.R. 7845 NIH Clinical Trial Diversity Act; a bill to direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes. H.R. 8185/S. 4440 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2023 through 2027 S. 4260 - Palliative Care and Hospice Education and Training Act; a bill to increase the number of permanent faculty in palliative care at accredited allopathic and osteopathic medical schools, nursing schools, social work schools, and other programs, including physician assistant education programs, to promote education and research in palliative care and hospice, and to support the development of faculty careers in academic palliative medicine. H.R. 7667/S. 4348 - Food and Drug Amendments of 2022; a bill to reauthorize Food and Drug Administration (FDA) user fee programs for certain drugs and devices, establishes requirements to increase diversity in clinical trials, and modifies requirements relating to the overall supply chain for drugs and devices. H.R. 9565/S. 5295- Comprehensive Cancer Survivorship Act; a bill to address the health of cancer survivors and unmet needs that survivors face through the entire continuum of care from diagnosis through active treatment and posttreatment, in order to improve survivorship, treatment, transition to recovery and beyond, quality of life and palliative care, and long-term health outcomes, including by developing a minimum standard of care for cancer survivorship, irrespective of the type of cancer, a survivors background, or forthcoming survivorship needs, and for other purposes. Policies related to telehealth Policies to increase clinical trial diversity and access for underrepresented populations Policies related to genetic counseling and testing Policies related to cancer survivorship Policies related to PBM and drug cost transparency Policies related to the reauthorization of FDA User Fee Agreements Policies related to the implementation of the Breast Density and Mammography Reporting Act of 2017 Policies related to the implementation of the Mammography Quality Standards Act Policies related to administration actions necessary in breast imaging and breast cancer diagnosis Comments regarding a request for information on establishing a National Directory of Healthcare Providers and Services
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
2022 · fourth_quarter · Medicare/Medicaid
Issues concerning access to the Medicare hospice benefit and palliative care. Issues regarding reimbursement for the Medicare hospice benefit. Issues related to community based palliative care and advanced care illness management. Issues related to regulatory relief. Issues concerning Medicare Advantage and the hospice benefit. Issues related to hospice coding as it relates to telehealth and spiritual care. Issues related to hospice telehealth flexibilities. Issues regarding program integrity. Issues regarding bereavement care. Issues concerning hospice payment and alternative payment models. Issues regarding in-patient and in-home respite care. Issues related to the extension of the COVID-19 public health emergency. Issues related to regulatory flexibilities granted under the public health emergency. Issues related to the hospice and palliative care workforce. Issues pertaining to the hospice election statement and election statement addendum. Issues pertaining to concurrent care. Issues related to children's access to hospice and palliative care. The extension of sequestration relief provided under the Protecting Medicare and American Farmers from Sequester Cuts Act (H.R. 610). The Childrens Program of All-inclusive Coordinated Care (ChiPACC) Act of 2021 (H.R. 4952); H.R. 2471 (P.L. 117-103), The Palliative Care and Hospice Education and Training Act (PCHETA) (S. 4260); Hospice Telehealth flexibilities, including H.R. 4040, Advancing Telehealth BeyondCovid-19 Act of 2021; S. 368 / H.R. 1332, the Telehealth Modernization Act; S. 1512 / H.R. 2903, The Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) Act, and H .R.8505 - To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes, as they relate to use of telehealth in the certification of a beneficiary for the hospice benefit. Issues related to the implementation of the Helping Our Senior Population in Comfort Environments (HOSPICE) Act. H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023 and issues concerning hospice reimbursement, and bereavement care.
Client expense: $260,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · fourth_quarter · Health Issues
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Inflation Reduction Act, HR 5376 - extension of expanded tax credits for ACA marketplaces; HR 1550, The Prevent HPV Cancers Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 S. 4260, The Palliative Care and Hospice Education and Training Act Provider Training in Palliative Care Act, S 2890 Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act Proposed Rule on Affordability of Employer Coverage for Family Members of Employees, REG-114339-21 Regulations related to short term limited duration health insurance plans (upcoming) OMB RFI on health equity - comments DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act, HR 6584 Give Kids a Chance Act, H.R. 6972 NIH Clinical Trials Diversity Act, HR 7845 HR 7667, Food and Drug Amendments Act Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, S 4348 S. 4185, the Retaining Access and Restoring Exclusivity (RARE) Act Potential legislation on cancer survivorship being developed by Rep. Wasserman Schultz Health Equity and Accountability Act, HR 7585 Notice of Benefit and Payment Parameters, regulatory comments Regulatory issues related to healthy food and dietary guidelines
Client expense: $1,990,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office
2022 · fourth_quarter · Health Issues
Issues regarding healthcare work force shortages. Issues regarding the PHE extension. S. 4260, Palliative Care and Hospice Education & Training Act (PCHETA). Issues related to community based palliative care. H.R. 9109, The Grief Resilience Investment and Education Fund (GRIEF) Act and issues regarding bereavement care. H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023, as it relates to PCHETA and bereavement care.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
S. 4260, Palliative Care and Hospice Education and Training Act. Allowance of distribution of personal retirement account funding for aging in place home modifications.
Client expense: $250,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
2022 · fourth_quarter · Health Issues
Issues related to health care workforce including Healthcare Workforce Resilience Act (H.R. 2255 / S. 1024) and the Provider Training in Palliative Care Act (S. 2890). S. 4260, Palliative Care and Hospice Education & Training Act. and H.R. 8812, the Improving Care and Access to Nurses (ICAN) Act. Issues related to community based palliative care and advanced care illness management. H.R. 9109, The Grief Resilience Investment and Education Fund (GRIEF) Act and issues regarding bereavement care. Issues related to safe opioid disposal and implementing the Support Act (H.R. 2379).
Client expense: $250,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
S.56/H.R. 1474 Alzheimer's Caregiver Support Act Americans Giving Care to Elders (AGE) Act of 2021 (H.R. 3689/S. 234) S.104 Improving Social Determinants of Health Act of 2021 National Coronavirus Commission Act of 2021 (H.R. 1306/S. 412) Advancing Connectivity during the Coronavirus to Ensure Support for Seniors (ACCESS) Act (H.R. 596/ S. 57) NIH supplemental funding S.333 COVID-19 Nursing Home Protection Act of 2021 S.962 American Cures Act S.674 Public Health Infrastructure Saves Lives Act FDA Neuroscience Center of Excellence BRAIN Initiative funding PACE Plus Act (S. 1162) Nursing Home Reform Modernization Act (H.R. 1985/ S. 782) Homecare for Seniors Act (H.R. 2898/S. 1399) COVID HCBS Relief Act of 2021 (H.R. 525/S. 151) Long-term care provisions within H.R.1319 the American Rescue Plan Act of 2021 Credit for Caring Act (H.R. 3321/S. 1670) Comprehensive Care for Alzheimer's Act (H.R. 2517/S. 1125) Equity in Neuroscience & Alzheimer's Clinical Trials (ENACT) Act of 2021 (H.R. 3085/S. 1548) Elder Abuse Protection Act of 2021 (H.R. 2922) Reducing COVID-19 Disparities by Investing in Public Health Act (H.R. 3904) PROTECTS Act (S. 2214) Provider Training in Palliative Care Act (S. 2890) Choose Home Care Act of 2021 (S. 2562/H.R 5514) Direct Care Opportunity Act (H.R. 2999) Inflation Reduction Act of 2022 (H.R.5376) Cures 2.0 Act (H.R. 6000) Innovation in Aging Act (S. 3473) Revitalizing the Aging Network Act (S. 3431) Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act (S. 2706/H.R. 5030) Stop the Wait Act of 2022 (S. 3575/H.R. 6583) Palliative Care and Hospice Education and Training Act (S. 4260) NAPA Reauthorization Act (H.R. 7775/S. 4203) Alzheimer's Accountability and Investment Act (H.R. 7773/S. 4202) IMPROVE Nursing Homes Act (H.R. 8677) Kevin and Avonte's Reauthorization Act of 2022 (H.R. 8907/S. 4885) Modernizing Accelerated Approval Pathway Act (S. 4446) Mandating Exclusive Review of Individual Treatments (MERIT) Act (H.R. 9127) Access to Innovative Treatments Act of 2022 (H.R. 9358) Consolidated Appropriations Act, 2023 (H.R. 2617) National Concussion Surveillance System (NCSS) funding at the CDC Other matters related to COVID -19 and long COVID Other matters related to elder justice Other matters related to dementia care management models Other matters related to younger-onset Alzheimer's disease Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease Other matters related to home- and community-based services Other matters related to diversity in clinical trials Other matters related to caregiving Other matters related to biomedical research, Alzheimer's diagnostics, and patient-focused drug development Other matters related to Social Security Other matters related to related to user fee agreements and accelerated approval
Client expense: $490,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
2022 · fourth_quarter · Health Issues
Issues related to quality of life, survivorship and access to care and therapeutics for cancer patients including S. 4260, the Palliative Care and Hospice Education and Training Act; Extension of federal telehealth policies post-pandemic including S. 1512, the Connect for Health Act among others telehealth bills; reform of the oversight of Laboratory Developed Tests as outlined in S.2209/HR 4128 the VALID Act and S 3799 the PREVENT Pandemics Act; HR 5376, the Inflation Reduction Act and HR 3630/S 1315 Lymphedema Treatment Act.
Client expense: $122,569 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
Issues related to health care workforce including H.R. 2255 / S. 1024, Healthcare Workforce Resilience Act and S. 2890, the Provider Training in Palliative Care Act. S. 4260, Palliative Care and Hospice Education & Training Act (PCHETA). H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023, as it relates to PCHETA and bereavement care. Issues related to community based palliative care. H.R. 9109, The Grief Resilience Investment and Education Fund (GRIEF) Act.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
Workforce development and clinical training site issues Issues surrounding opioid use disorders and medication-assisted treatment H.R. 2067/S.2235 - Medication Access and Training Expansion (MATE) Act H.R.945/S. 287 - Perinatal Workforce Act H.R. 959/S.346 - the Black Maternal Health Momnibus Act Telehealth issues, such as integrating students into telemedicine appointments H.R. 3890 - Physician Assistant Education Public Health Initiatives Act H.R. 5035/S. 2982 - Child Suicide Prevention and Lethal Means Safety Act H.R. 5602/S. 3244 - BIO Preparedness Workforce Act S. 4260 - Palliative Care and Hospice Education and Training Act S. 3799 - PREVENT Pandemics Act S. 4170 - Mental Health Reform Reauthorization Act of 2022
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Health Issues
Workforce development and clinical training site issues Issues surrounding opioid use disorders and medication-assisted treatment H.R. 2067/S.2235 - Medication Access and Training Expansion (MATE) Act H.R.945/S. 287 - Perinatal Workforce Act H.R. 959/S.346 - the Black Maternal Health Momnibus Act Telehealth issues, such as integrating students into telemedicine appointments H.R. 3890 - Physician Assistant Education Public Health Initiatives Act H.R. 5035/S. 2982 - Child Suicide Prevention and Lethal Means Safety Act H.R. 5602/S. 3244 - BIO Preparedness Workforce Act S. 4260 - Palliative Care and Hospice Education and Training Act S. 3799 - PREVENT Pandemics Act S. 4170 - Mental Health Reform Reauthorization Act of 2022
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · third_quarter · Health Issues
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Inflation Reduction Act, HR 5376 - extension of expanded tax credits for ACA marketplaces; HR 1550, The Prevent HPV Cancers Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 S. 4260, The Palliative Care and Hospice Education and Training Act Provider Training in Palliative Care Act, S 2890 Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act Proposed Rule on Affordability of Employer Coverage for Family Members of Employees, REG-114339-21 Regulations related to short term limited duration health insurance plans (upcoming) OMB RFI on health equity - comments DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act, HR 6584 Give Kids a Chance Act, H.R. 6972 NIH Clinical Trials Diversity Act, HR 7845 HR 7667, Food and Drug Amendments Act Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, S 4348 S. 4185, the Retaining Access and Restoring Exclusivity (RARE) Act Potential legislation on cancer survivorship being developed by Rep. Wasserman Schultz Health Equity and Accountability Act, HR 7585 Notice of Benefit and Payment Parameters, regulatory comments Regulatory issues related to healthy food and dietary guidelines
Client expense: $1,200,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office
2022 · third_quarter · Health Issues
H.R. 379/S. 104 - Improving Social Determinants of Health Act; bill to require the Centers for Disease Control and Prevention (CDC) to establish a program to improve health outcomes and reduce health inequities by, for example, coordinating activities across the CDC. As part of the program, the CDC must award grants to eligible organizations to build capacity to address social determinants of health. H.R. 469 - Comprehensive Breast Reconstruction Act of 2021; bill provides for Medicare, Medicaid, and private health insurance coverage of certain tattooing services in connection with post-mastectomy breast reconstruction, and aligns the scope of Medicare and Medicaid coverage of such breast reconstruction with that of private health insurance. H.R. 5030/S.2706 - DIVERSE Trials Act; A bill to require FDA to issue guidance on decentralized clinical trials to promote meaningful demographic/geographic diversity in patient engagment, expand reporting by laboratories that test for and diagnose COVID-19, and require a study on data collection and data sharing during public health emergencies H.R. 6000 - Cures 2.0 Act; a comprehensive healthcare and biomedical research bill H.R. 4794/S. 2533 - Making Advances in Mammography and Medical Options for Veterans Act; a bill to improve mammography services furnished by the Department of Veterans Affairs H.R. 4571/S. 2102 - Supporting Expanded Review for Veterans in Combat Environments (SERVICE) Act of 2021; a bill to expand eligibility for Veterans Health Administration mammography screenings to veterans who served in certain locations during specified periods, including those who were exposed to toxic substances at such locations H.R. 6584 - Diverse and Equitable Participation in Clinical Trials (DEPICT) Act; a bill to direct the Commissioner of Food and Drugs to amend certain regulations to increase clinical trial diversity, and for other purposes. S. 3799 - Prepare for and Respond to Existing Viruses, Emerging New Threats, (PREVENT) and Pandemics Act; a bill to prepare for, and respond to, existing viruses, emerging new threats, and pandemics. Efforts to introduce a bill regarding clinical trial diversity nicknamed the The Clinical Trial Diversity Act H.R. 7845 NIH Clinical Trial Diversity Act; a bill to direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes. H.R. 8185/S. 4440 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2023 through 2027 S. 4260 - Palliative Care and Hospice Education and Training Act; a bill to increase the number of permanent faculty in palliative care at accredited allopathic and osteopathic medical schools, nursing schools, social work schools, and other programs, including physician assistant education programs, to promote education and research in palliative care and hospice, and to support the development of faculty careers in academic palliative medicine. H.R. 7667/S. 4348 - Food and Drug Amendments of 2022; a bill to reauthorize Food and Drug Administration (FDA) user fee programs for certain drugs and devices, establishes requirements to increase diversity in clinical trials, and modifies requirements relating to the overall supply chain for drugs and devices. Policies related to telehealth Policies related to COVID-19 vaccination and monoclonal antibody distribution Policies to increase clinical trial diversity and access for underrepresented populations Policies related to genetic counseling and testing Policies related to cancer survivorship Policies related to PBM and drug cost transparency Policies related to the reauthorization of FDA User Fee Agreements Policies related to the implementation of the Breast Density and Mammography Reporting Act of 2017
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
2022 · third_quarter · Health Issues
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Inflation Reduction Act, HR 5376 - extension of expanded tax credits for ACA marketplaces; HR 1550, The Prevent HPV Cancers Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 S. 4260, The Palliative Care and Hospice Education and Training Act Provider Training in Palliative Care Act, S 2890 Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act Proposed Rule on Affordability of Employer Coverage for Family Members of Employees, REG-114339-21 Regulations related to short term limited duration health insurance plans (upcoming) OMB RFI on health equity - comments DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act, HR 6584 Give Kids a Chance Act, H.R. 6972 NIH Clinical Trials Diversity Act, HR 7845 HR 7667, Food and Drug Amendments Act Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, S 4348 S. 4185, the Retaining Access and Restoring Exclusivity (RARE) Act Potential legislation on cancer survivorship being developed by Rep. Wasserman Schultz Health Equity and Accountability Act, HR 7585 Notice of Benefit and Payment Parameters, regulatory comments Regulatory issues related to healthy food and dietary guidelines
Client expense: $1,200,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office
2022 · third_quarter · Health Issues
Issues related to quality of life, survivorship and access to care and therapeutics for cancer patients including S. 4260, the Palliative Care and Hospice Education and Training Act; Extension of federal telehealth policies post-pandemic including S. 1512, the Connect for Health Act among others telehealth bills; reform of the oversight of Laboratory Developed Tests as outlined in S.2209/HR 4128 the VALID Act and S 3799 the PREVENT Pandemics Act; HR 5376, the Inflation Reduction Act and HR 3630/S 1315 Lymphedema Treatment Act.
Client expense: $140,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medicare/Medicaid
Issues concerning access to the Medicare hospice benefit and palliative care. Issues regarding reimbursement for the Medicare hospice benefit. Issues related to community based palliative care and advanced care illness management. Issues related to regulatory relief. Issues concerning Medicare Advantage and the hospice benefit. Issues related to COVID. H.R. 4040, Advancing Telehealth Beyond Covid-19 Act of 2021; S. 368 / H.R. 1332, the Telehealth Modernization Act; as they relate to use of telehealth in the certification of a beneficiary for the hospice benefit. S. 1512 / H.R. 2903, The Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) Act. Medicare sequestration relief. Issues regarding program integrity. H.R. 5376 (P.L. 117-169), the Inflation Reduction Act, as it relates to home and community-based services and palliative care. S. 2565, Expanding Access to Palliative Care Act. Issues regarding bereavement care. The FY 2023 Proposed Hospice Wage Rule, as it relates to hospice reimbursement. H.R.8505 - To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes. Issues related to hospice codes. Issues related to hospice telehealth flexibilities. Issues concerning hospice payment and alternative payment models. Issues regarding in-patient and in-home respite care. Issues related to COVID-19 emergency funding, extension of the public health emergency, testing, vaccines, and COVID-19 related legislation. Issues related to regulatory flexibilities granted under the public health emergency. Issues related to the hospice and palliative care workforce. Issues pertaining to the hospice election statement and election statement addendum. Issues pertaining to concurrent care. Issues related to children's access to hospice and palliative care. The extension of sequestration relief provided under H.R.1868, Medicare Sequester COVID Moratorium Act (H.R. 315), and Protecting Medicare and American Farmers from Sequester Cuts Act (H.R. 610); The Children's Program of All-inclusive Coordinated Care (ChiPACC) Act of 2021 (H.R. 4952); H.R. 2471 (P.L. 117-103), The Palliative Care and Hospice Education and Training Act (PCHETA) (S. 4260); The Telehealth Extension & Evaluation Act (S. 3593); the Telehealth Extension Act (H.R. 6202). Medicare Hospice Payment Rule. Issues related to the implementation of the Helping Our Senior Population in Comfort Environments (HOSPICE) Act and the Rural Access to Hospice Act.
Client expense: $280,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · third_quarter · Health Issues
Older American Act reauthorization. S. 2890, Provider Training in Palliative Care Act. S. 4260, Palliative Care and Hospice Education and Training Act. Reestablishment of House Aging Committee. Allowance of distribution of personal retirement account funding for aging in place home modifications.
Client expense: $230,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
2022 · third_quarter · Health Issues
Issues related to quality of life, survivorship and access to care and therapeutics for cancer patients including S. 4260, the Palliative Care and Hospice Education and Training Act; Extension of federal telehealth policies post-pandemic including S. 1512, the Connect for Health Act among others telehealth bills; reform of the oversight of Laboratory Developed Tests as outlined in S.2209/HR 4128 the VALID Act and S 3799 the PREVENT Pandemics Act; HR 5376, the Inflation Reduction Act and HR 3630/S 1315 Lymphedema Treatment Act.
Client expense: $78,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
Issues related to health care workforce including Healthcare Workforce Resilience Act (H.R. 2255 / S. 1024) and the Provider Training in Palliative Care Act (S. 2890). S. 4260, Palliative Care and Hospice Education & Training Act. and H.R. 8812, the Improving Care and Access to Nurses (ICAN) Act. Issues related to community based palliative care and advanced care illness management. H.R. 9109, The Grief Resilience Investment and Education Fund (GRIEF) Act and issues regarding bereavement care. Issues related to safe opioid disposal and implementing the Support Act (H.R. 2379).
Client expense: $240,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
S.56/H.R. 1474 Alzheimer's Caregiver Support Act Americans Giving Care to Elders (AGE) Act of 2021 (H.R. 3689/S. 234) S.104 Improving Social Determinants of Health Act of 2021 National Coronavirus Commission Act of 2021 (H.R. 1306/S. 412) Advancing Connectivity during the Coronavirus to Ensure Support for Seniors (ACCESS) Act (H.R. 596/ S. 57) NIH supplemental funding S.333 COVID-19 Nursing Home Protection Act of 2021 S.962 American Cures Act S.674 Public Health Infrastructure Saves Lives Act FDA Neuroscience Center of Excellence BRAIN Intiative funding PACE Plus Act (S. 1162) Nursing Home Reform Modernization Act (H.R. 1985/ S. 782) Homecare for Seniors Act (H.R. 2898/S. 1399) COVID HCBS Relief Act of 2021 (H.R. 525/S. 151) Long-term care provisions within H.R.1319 the American Rescue Plan Act of 2021 Credit for Caring Act (H.R. 3321/S. 1670) Comprehensive Care for Alzheimer's Act (H.R. 2517/S. 1125) Equity in Neuroscience & Alzheimer's Clinical Trials (ENACT) Act of 2021 (H.R. 3085/S. 1548) Elder Abuse Protection Act of 2021 (H.R. 2922) Reducing COVID-19 Disparities by Investing in Public Health Act (H.R. 3904) PROTECTS Act (S. 2214) Provider Training in Palliative Care Act (S. 2890) Choose Home Care Act of 2021 (S. 2562/H.R 5514) Direct Care Opportunity Act (H.R. 2999) Inflation Reduction Act of 2022 (H.R.5376) Cures 2.0 Act (H.R. 6000) Innovation in Aging Act (S. 3473) Revitalizing the Aging Network Act (S. 3431) Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act (S. 2706/H.R. 5030) Stop the Wait Act of 2022 (S. 3575/H.R. 6583) Palliative Care and Hospice Education and Training Act (S.4260) NAPA Reauthorization Act (H.R. 7775/S 4203) Alzheimer's Accountability and Investment Act (H.R. 7773/S 4202) IMPROVE Nursing Homes Act (H.R. 8677) Kevin and Avonte's Reauthorization Act of 2022 (H.R. 8907/S. 4885) Mandating Exclusive Review of Individual Treatments (MERIT) Act (H.R. 9127) Other matters related to COVID -19 and long COVID Other matters related to elder justice Other matters related to dementia care management models Other matters related to younger-onset Alzheimer's disease Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease Other matters related to home- and community-based services Other matters related to diversity in clinical trials Other matters related to caregiving Other matters related to biomedical research, Alzheimer's diagnostics, and patient-focused drug development Other matters related to Social Security Other matters related to related to user fee agreements and accelerated approval
Client expense: $690,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
2022 · third_quarter · Health Issues
Issues related to health care workforce including Healthcare Workforce Resilience Act (H.R. 2255 / S. 1024) and the Provider Training in Palliative Care Act (S. 2890). S. 4260, Palliative Care and Hospice Education & Training Act. Issues related to community based palliative care and advanced care illness management. H.R. 9109, The Grief Resilience Investment and Education Fund (GRIEF) Act and issues regarding bereavement care.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
Issues regarding healthcare work force shortages. S. 4260, Palliative Care and Hospice Education & Training Act. Issues related to community based palliative care & advanced care illness management. H.R. 9109, The Grief Resilience Investment and Education Fund (GRIEF) Act and issues regarding bereavement care.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medicare/Medicaid
Preserving Access to Home Health Act of 2022 (S. 4605/H.R. 8581 Palliative Care and Hospice Education and Training Act (S.4260) Better Care Better Jobs Act (S. 2210/H.R. 4131)
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
Workforce development and clinical training site issues Issues surrounding opioid use disorders and medication-assisted treatment H.R. 2067/S.2235 - Medication Access and Training Expansion (MATE) Act H.R.945/S. 287 - Perinatal Workforce Act H.R. 959/S.346 - the Black Maternal Health Momnibus Act Telehealth issues, such as integrating students into telemedicine appointments H.R. 3890 - Physician Assistant Education Public Health Initiatives Act H.R. 5035/S. 2982 - Child Suicide Prevention and Lethal Means Safety Act H.R. 5602/S. 3244 - BIO Preparedness Workforce Act S. 4260 - Palliative Care and Hospice Education and Training Act S. 3799 - PREVENT Pandemics Act S. 4170 - Mental Health Reform Reauthorization Act of 2022
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · second_quarter · Health Issues
H.R. 379/S. 104 - Improving Social Determinants of Health Act; bill to require the Centers for Disease Control and Prevention (CDC) to establish a program to improve health outcomes and reduce health inequities by, for example, coordinating activities across the CDC. As part of the program, the CDC must award grants to eligible organizations to build capacity to address social determinants of health. H.R. 469 - Comprehensive Breast Reconstruction Act of 2021; bill provides for Medicare, Medicaid, and private health insurance coverage of certain tattooing services in connection with post-mastectomy breast reconstruction, and aligns the scope of Medicare and Medicaid coverage of such breast reconstruction with that of private health insurance. H.R. 5030/S.2706 - DIVERSE Trials Act; A bill to require FDA to issue guidance on decentralized clinical trials to promote meaningful demographic/geographic diversity in patient engagment, expand reporting by laboratories that test for and diagnose COVID-19, and require a study on data collection and data sharing during public health emergencies H.R. 6000 - Cures 2.0 Act; a comprehensive healthcare and biomedical research bill H.R. 4794/S. 2533 - Making Advances in Mammography and Medical Options for Veterans Act; a bill to improve mammography services furnished by the Department of Veterans Affairs H.R. 4571/S. 2102 - Supporting Expanded Review for Veterans in Combat Environments (SERVICE) Act of 2021; a bill to expand eligibility for Veterans Health Administration mammography screenings to veterans who served in certain locations during specified periods, including those who were exposed to toxic substances at such locations H.R. 6584 - Diverse and Equitable Participation in Clinical Trials (DEPICT) Act; a bill to direct the Commissioner of Food and Drugs to amend certain regulations to increase clinical trial diversity, and for other purposes. S. 3799 - Prepare for and Respond to Existing Viruses, Emerging New Threats, (PREVENT) and Pandemics Act; a bill to prepare for, and respond to, existing viruses, emerging new threats, and pandemics. Efforts to introduce a bill regarding clinical trial diversity nicknamed the The Clinical Trial Diversity Act H.R. 7845 NIH Clinical Trial Diversity Act; a bill to direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes. H.R. 8185/S. 4440 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2023 through 2027 S. 4260 - Palliative Care and Hospice Education and Training Act; a bill to increase the number of permanent faculty in palliative care at accredited allopathic and osteopathic medical schools, nursing schools, social work schools, and other programs, including physician assistant education programs, to promote education and research in palliative care and hospice, and to support the development of faculty careers in academic palliative medicine. H.R. 7667/S. 4348 - Food and Drug Amendments of 2022; a bill to reauthorize Food and Drug Administration (FDA) user fee programs for certain drugs and devices, establishes requirements to increase diversity in clinical trials, and modifies requirements relating to the overall supply chain for drugs and devices. Policies related to telehealth Policies related to COVID-19 vaccination and monoclonal antibody distribution Policies to increase clinical trial diversity and access for underrepresented populations Policies related to genetic counseling and testing Policies related to cancer survivorship Policies related to PBM and drug cost transparency Comments to FTC regarding a Request for Information on Pharmacy Benefit Managers practices (FTC-2022-0015) Comments to FDA on the Draft Guidance For Industry: Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials (FDA-2021-D0789)
Client expense: $80,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
2022 · second_quarter · Health Issues
S.56/H.R. 1474 Alzheimer's Caregiver Support Act Americans Giving Care to Elders (AGE) Act of 2021 (H.R. 3689/S. 234) S.104 Improving Social Determinants of Health Act of 2021 National Coronavirus Commission Act of 2021 (H.R. 1306/S. 412) Advancing Connectivity during the Coronavirus to Ensure Support for Seniors (ACCESS) Act (H.R. 596/ S. 57) NIH supplemental funding S.333 COVID-19 Nursing Home Protection Act of 2021 S.962 American Cures Act S.674 Public Health Infrastructure Saves Lives Act FDA Neuroscience Center of Excellence BRAIN Intiative funding PACE Plus Act (S. 1162) Nursing Home Reform Modernization Act (H.R. 1985/ S. 782) Homecare for Seniors Act (H.R. 2898/S. 1399) COVID HCBS Relief Act of 2021 (H.R. 525/S. 151) Long-term care provisions within H.R.1319 the American Rescue Plan Act of 2021 Credit for Caring Act (H.R. 3321/S. 1670) Comprehensive Care for Alzheimer's Act (H.R. 2517/S. 1125) Equity in Neuroscience & Alzheimer's Clinical Trials (ENACT) Act of 2021 (H.R. 3085/S. 1548) Elder Abuse Protection Act of 2021 (H.R. 2922) Reducing COVID-19 Disparities by Investing in Public Health Act (H.R. 3904) PROTECTS Act (S. 2214) Provider Training in Palliative Care Act (S. 2890) Choose Home Care Act of 2021 (S. 2562/H.R 5514) Direct Care Opportunity Act (H.R. 2999) Build Back Better Act (H.R.5376) Cures 2.0 Act (H.R. 6000) Innovation in Aging Act (S. 3473) Revitalizing the Aging Network Act (S. 3431) Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act (S. 2706/H.R. 5030) Stop the Wait Act (S. 3575/H.R. 6583) Palliative Care and Hospice Education and Training Act (S.4260) NAPA Reauthorization Act (H.R. 7775/S 4203) Alzheimer's Accountability and Investment Act (H.R. 7773/S 4202) Other matters related to COVID -19 and long COVID Other matters related to elder justice Other matters related to dementia care management models Other matters related to younger-onset Alzheimer's disease Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease Other matters related to home- and community-based services Other matters related to diversity in clinical trials Other matters related to caregiving Other matters related to biomedical research, Alzheimer's diagnostics, and patient-focused drug development Other matters related to Social Security Other matters related to related to user fee agreements and accelerated approval
Client expense: $1,310,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
2022 · second_quarter · Health Issues
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions - ACA tax credits permanency HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 S. 4260, The Palliative Care and Hospice Education and Training Act Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Surprises Act Proposed Rule on Affordability of Employer Coverage for Family Members of Employees, REG-114339-21 Regulations related to short term limited duration health insurance plans OMB RFI on health equity - comments DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972 NIH Clinical Trials Diversity Act HR 7667, Food and Drug Amendments Act Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, S 4348 S. 4185, the Retaining Access and Restoring Exclusivity (RARE) Act Potential legislation on cancer survivorship being developed by Rep. Wasserman Schultz Health Equity and Accountability Act, HR 7585
Client expense: $940,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), White House Office
2022 · second_quarter · Health Issues
Older American Act reauthorization. S. 2890, Provider Training in Palliative Care Act. S. 4260, Palliative Care and Hospice Education and Training Act. Reestablishment of House Aging Committee. Allowance of distribution of personal retirement account funding for aging in place home modifications.
Client expense: $220,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
2022 · second_quarter · Health Issues
Issues regarding healthcare work force shortages. Monitored the implementation of P.L. 117-2, the American Rescue Plan, as it relates to the provider relief fund. S. 4260 Palliative Care and Hospice Education and Training Act (PCHETA) and issues supporting the workforce
Client expense: $230,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
S.56/H.R. 1474 Alzheimer's Caregiver Support Act Americans Giving Care to Elders (AGE) Act of 2021 (H.R. 3689/S. 234) S.104 Improving Social Determinants of Health Act of 2021 National Coronavirus Commission Act of 2021 (H.R. 1306/S. 412) Advancing Connectivity during the Coronavirus to Ensure Support for Seniors (ACCESS) Act (H.R. 596/ S. 57) NIH supplemental funding S.333 COVID-19 Nursing Home Protection Act of 2021 S.962 American Cures Act S.674 Public Health Infrastructure Saves Lives Act FDA Neuroscience Center of Excellence BRAIN Intiative funding PACE Plus Act (S. 1162) Nursing Home Reform Modernization Act (H.R. 1985/ S. 782) Homecare for Seniors Act (H.R. 2898/S. 1399) COVID HCBS Relief Act of 2021 (H.R. 525/S. 151) Long-term care provisions within H.R.1319 the American Rescue Plan Act of 2021 Credit for Caring Act (H.R. 3321/S. 1670) Comprehensive Care for Alzheimer's Act (H.R. 2517/S. 1125) Equity in Neuroscience & Alzheimer's Clinical Trials (ENACT) Act of 2021 (H.R. 3085/S. 1548) Elder Abuse Protection Act of 2021 (H.R. 2922) Reducing COVID-19 Disparities by Investing in Public Health Act (H.R. 3904) PROTECTS Act (S. 2214) Provider Training in Palliative Care Act (S. 2890) Choose Home Care Act of 2021 (S. 2562/H.R 5514) Direct Care Opportunity Act (H.R. 2999) Build Back Better Act (H.R.5376) Cures 2.0 Act (H.R. 6000) Innovation in Aging Act (S. 3473) Revitalizing the Aging Network Act (S. 3431) Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act (S. 2706/H.R. 5030) Stop the Wait Act (S. 3575/H.R. 6583) Palliative Care and Hospice Education and Training Act (S.4260) NAPA Reauthorization Act (H.R. 7775/S 4203) Alzheimer's Accountability and Investment Act (H.R. 7773/S 4202) Other matters related to COVID -19 and long COVID Other matters related to elder justice Other matters related to dementia care management models Other matters related to younger-onset Alzheimer's disease Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease Other matters related to home- and community-based services Other matters related to diversity in clinical trials Other matters related to caregiving Other matters related to biomedical research, Alzheimer's diagnostics, and patient-focused drug development Other matters related to Social Security Other matters related to related to user fee agreements and accelerated approval
Client expense: $13,100,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
2022 · second_quarter · Health Issues
Issues related to health care workforce issues including Healthcare Workforce Resilience Act (H.R. 2255 / S. 1024) and the Provider Training in Palliative Care Act (S. 2890). S. 4260, Palliative Care and Hospice Education & Training Act. Issues related to community based palliative care and advanced care illness management.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Medicare/Medicaid
Urged congress and the Centers for Medicare and Medicaid Services to address the potential loss of coverage for millions of Medicaid beneficiaries at the end of the federal public health emergency (PHE) and specifically asked for at least a 120-day lead time before unwinding the FMAP and Maintenance of effort provisions of the FFCRA. Urged the House Energy and Commerce Committee to move forward with existing legislation approved by the Subcommittee on Health that would address several social determinants of health and health equity issues. This legislation would allow for better coordination among federal agencies to address health equity, support state and local governments in efforts to address the social determinants of health and promote efforts and innovative approaches to improve health outcomes in programs such as Medicaid. (S. 2938) - Bipartisan Safer Communities Act - Expressed support for the Bipartisan Safer Communities Act. The passage of Medicaid improvements in the Bipartisan Safer Communities Act will begin to build the foundation for addressing the nationwide mental health and substance use crisis, particularly for children. (S. 4311) - LIFT the Bar Act - Expressed support for legislation introduced to eliminate the five year-bar, a 1996 policy that denies eligibility for federal assistance programs including Medicaid to millions of immigrants who are lawfully present in the United States. (S. 4260) - Palliative Care and Hospice Education and Training Act (PCHETA) - Expressed support for the Palliative Care and Hospice Education and Training Act (PCHETA). This legislation would ensure that patients facing serious illness have access to high quality palliative care. Urged congress to include critical health care funding measures in the FY22 Omnibus bill including measures to provide relief for providers and the Medicare and Medicaid programs. Urged congress to prioritize policy proposals to strengthen Medicaid and ensure its stability for underrepresented populations who rely on this critical program. Urged the Administration to address longstanding and systemic issues that have resulted from underinvesting in nursing home care, including racial and ethnic disparities, and offer our thoughts on the following three issues: Sustainable financing, Workforce concerns, and Enhancing nursing home oversight through innovative partnerships. Urged the Senate to renew its efforts to pass a reconciliation bill that invests in our nations future and well-being by ensuring important health coverage policies that expand access and affordability and address health equity, address climate change and promote initiatives to protect our environment, and include policies that protect Medicaid beneficiaries, providers, and communities after the end of the public health emergency.
Client expense: $234,804 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, President of the U.S., SENATE
2022 · second_quarter · Health Issues
Monitored the implementation of The American Rescue Plan Act (H.R. 1319) as it relates to the Provider Relief Fund; the extension of sequestration relief provided under H.R.1868, the Medicare Sequester COVID Moratorium Act (H.R. 315) and Protecting Medicare and American Farmers from Sequester Cuts Act (H.R. 610); the Telehealth Modernization Act (S. 368/H.R.1332) and the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) Act (S. 1512/H.R. 2903) as it relates to use of telehealth in the certification of a beneficiary for the hospice benefit; The Childrens Program of All-inclusive Coordinated Care (ChiPACC) Act of 2021 (H.R. 4952); The Expanding Access to Palliative Care Act (S. 2565). The Palliative Care and Hospice Education and Training Act (PCHETA) (S. 4260); The Build Back Better Act (H.R. 5376) as it relates to Home and Community Based Services and palliative care training and education; The Health Care Workforce Resilience Act (S. 1024/H.R. 2255); The Provider Training in Palliative Care Act (S. 2890) The Palliative Care Training for Providers Act (H.R. 5376); The Consolidated Appropriations Act, 2022 (H.R. 2471) as related to Medicare sequester relief, telehealth flexibilities, and hospice payment reimbursement; Issues regarding bereavement care; Issues related to regulatory relief; Issues involving hospice providers and COVID relief; Issues related to coronavirus; Telehealth Extension and Evaluation Act (S. 3593); the Telehealth Extension Act (H.R. 6202). Issues related to healthcare workforce shortages; Issues related to community-based palliative care and advanced care illness management. S. 2938, The Bipartisan Safer Communities Act and issues concerning bereavement care.
Client expense: $280,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · second_quarter · Medicare/Medicaid
Issues concerning the Medicare Hospice Benefit and palliative care. Issues concerning hospice payment and alternative payment models. Issues related to community-based palliative care and advanced care illness management. Issues related to regulatory relief. Issues regarding in-patient and in-home respite care, bereavement care, palliative care and community-based palliative care. Issues related to COVID-19. Issues related to COVID-19 emergency funding, extension of the public health emergency, testing, vaccines, and COVID-19 related legislation. Issues related to telehealth flexibilities and regulatory flexibilities granted under the public health emergency. Issues related to the hospice and palliative care workforce. Issues concerning Medicare Advantage Value-Based Insurance Design and the hospice benefit. Issues pertaining to the hospice election statement and election statement addendum. Issues pertaining to concurrent care. Medicare sequestration relief. Issues related to children's access to hospice and palliative care. Issues related to program integrity. Issues involving mandatory COVID vaccines for healthcare providers. Monitored implementation of The American Rescue Plan Act (H.R. 1319) as it relates to the Provider Relief Fund; the extension of sequestration relief provided under H.R.1868, Medicare Sequester COVID Moratorium Act (H.R. 315), and Protecting Medicare and American Farmers from Sequester Cuts Act (H.R. 610); the Telehealth Modernization Act (S. 368/H.R. 1332) and the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) Act (S. 1512/H.R. 2903) as it relates to use of telehealth in the certification of a beneficiary for the hospice benefit; The Childrens Program of All-inclusive Coordinated Care (ChiPACC) Act of 2021 (H.R. 4952); The Expanding Access to Palliative Care Act (S. 2565); H.R. 2471 (P.L. 117-103), The Consolidated Appropriations Act of 2022 (H.R. 2471), as it relates to telehealth flexibilities, sequestration, and hospice reimbursement; The Palliative Care and Hospice Education and Training Act (PCHETA) (S. 4260); Issues regarding reimbursement for the Medicare hospice benefit; H.R. 5376, the Build Back Better Act as it relates to home and community-based services and palliative care. S. 3593, The Telehealth Extension & Evaluation Act (S. 3593); the Telehealth Extension Act (H.R. 6202). Medicare Hospice Payment Rule. Issues related to the implementation of the Helping Our Senior Population in Comfort Environments (HOSPICE) Act and the Rural Access to Hospice Act. FY 2023 Appropriations requests as they relate to bereavement and Medicare Advantage Value Based Insurance Design.
Client expense: $280,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · second_quarter · Health Issues
Issues regarding healthcare work force shortages. S. 4260, Palliative Care and Hospice Education & Training Act. Issues related to community based palliative care & advanced care illness management. Issues regarding bereavement care. S. 2938, The Bipartisan Safer Communities Act and issues concerning bereavement care.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · second_quarter · Health Issues
Issues related to quality of life, survivorship and access for cancer patients including S. 4260, the Palliative Care and Hospice Education and Training Act; Extension of federal telehealth policies post-pandemic including S. 1512, the Connect for Health Act among others telehealth bills; reform of the oversight of Laboratory Developed Tests as outlined in S.2209/HR 4128 the VALID Act and S 3799 the PREVENT Pandemics Act.
Client expense: $78,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Medicare/Medicaid
Choose Home Care Act (S. 2562/HR. 5514) Consolidated Appropriations Act, 2022 (H.R. 2471) Palliative Care and Hospice Education and Training Act (S.4260) CY 2023 Home Health Prospective Payment System Rate Update (Proposed Rule 87 FR 37600)
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE